Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes

被引:65
作者
Balzarini, Jan
Van Herrewege, Yven
Vermeire, Kurt
Vanham, Guido
Schols, Dominique
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Inst Trop Med, B-2000 Antwerp, Belgium
关键词
D O I
10.1124/mol.106.030155
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Exposure of HIV-1 to dendritic cell-specific intercellular adhesion molecule-3 -grabbing nonintegrin (DC-SIGN) -expressing B-lymphoblast Raji cells (Raji/DC-SIGN) but not to wild-type Raji/0 cells results in the capture of HIV-1 particles to the cells as measured by the quantification of cell-associated p24 antigen. Cocultivation of HIV-1 -captured Raji/DC-SIGN cells with uninfected CD4(+) T lymphocyte C8166 cells results in abundant formation of syncytia within 36 h after cocultivation. Short pre-exposure of HIV-1 to carbohydrate-binding agents (CBA) dose dependently prevents the Raji/DC-SIGN cells from efficiently binding the virus particles, and no syncytia formation occurs upon subsequent cocultivation with C8166 cells. Thus, the mannose-specific [i. e., the plant lectins Hippeastrum hybrid agglutinin (HHA), Galanthus nivalis agglutinin (GNA), Narcissus pseudonarcissus agglutinin; and Cymbidium agglutinin (CA); the procaryotic cyanovirin-N (CV-N); and the monoclonal antibody 2G12) and N-acetylglucosamine-specific (i. e., the plant lectin Urtica dioica agglutinin) CBAs efficiently abrogate the DC-SIGN-directed HIV-1 capture and subsequent transmission to T lymphocytes. In this assay, the CD4-down-regulating cyclotriazodisulfonamide derivative, the CXCR4 and CCR5 coreceptor antagonists 1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl) phenyl] methyl] -1,4,8,11-tetrazacyclotetradecane (AMD3100) and maraviroc, the gp41-binding enfuvirtide, and the polyanionic substances dextran sulfate (M-r 5000), sulfated polyvinyl alcohol, and the naphthalene sulfonate polymer PRO-2000 were markedly less efficient or even completely ineffective. Similar observations were made in primary monocyte-derived dendritic cell cultures that were infected with HIV-1 particles that had been shortly pre-exposed to the CBAs CV-N, CA, HHA, and GNA and the polyanions DS-5000 and PRO-2000. The potential of CBAs, but not polyanions and other structural/functional classes of entry inhibitors, to impair DC-SIGN-expressing cells in their capacity of transmitting HIV to T lymphocytes might be an important property to be taken into consideration in the eventual choice to move microbicide candidate drugs to the clinical setting.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 28 条
[1]  
BABA M, 1990, J ACQ IMMUN DEF SYND, V3, P493
[2]   NOVEL SULFATED POLYMERS AS HIGHLY POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION AND GIANT-CELL FORMATION [J].
BABA, M ;
SCHOLS, D ;
DECLERCO, E ;
PAUWELS, R ;
NAGY, M ;
GYORGYIEDELENYI, J ;
LOW, M ;
GOROG, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (01) :134-138
[3]   Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection [J].
Balzarini, J ;
Hatse, S ;
Vermeire, K ;
Princen, K ;
Aquaro, S ;
Perno, CF ;
De Clercq, E ;
Egberink, H ;
Vanden Mooter, G ;
Peumans, W ;
Van Damme, E ;
Schols, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3858-3870
[4]  
BALZARINI J, 2006, IN PRESS LANCET
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells [J].
Baribaud, F ;
Pöhlmann, S ;
Leslie, G ;
Mortari, F ;
Doms, RW .
JOURNAL OF VIROLOGY, 2002, 76 (18) :9135-9142
[7]   SYNERGISTIC INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN-MEDIATED CELL-FUSION AND INFECTION BY AN ANTIBODY TO CD4 DOMAIN-2 IN COMBINATION WITH ANTI-GP120 ANTIBODIES [J].
BURKLY, L ;
MULREY, N ;
BLUMENTHAL, R ;
DIMITROV, DS .
JOURNAL OF VIROLOGY, 1995, 69 (07) :4267-4273
[8]   CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site [J].
Clevestig, P ;
Pramanik, L ;
Leitner, T ;
Ehrnst, A .
JOURNAL OF GENERAL VIROLOGY, 2006, 87 :607-612
[9]   SEQUENCE AND EXPRESSION OF A MEMBRANE-ASSOCIATED C-TYPE LECTIN THAT EXHIBITS CD4-INDEPENDENT BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN-GP120 [J].
CURTIS, BM ;
SCHARNOWSKE, S ;
WATSON, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :8356-8360
[10]   Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity [J].
Dorr, P ;
Westby, M ;
Dobbs, S ;
Griffin, P ;
Irvine, B ;
Macartney, M ;
Mori, J ;
Rickett, G ;
Smith-Burchnell, C ;
Napier, C ;
Webster, R ;
Armour, D ;
Price, D ;
Stammen, B ;
Wood, A ;
Perros, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) :4721-4732